Filing Details
- Accession Number:
- 0001181431-14-034002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-08 16:33:15
- Reporting Period:
- 2014-10-08
- Filing Date:
- 2014-10-08
- Accepted Time:
- 2014-10-08 16:33:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1557883 | Dermira Inc. | DERM | Pharmaceutical Preparations (2834) | 273267680 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1452907 | New Enterprise Associates 13 Lp | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
| 1460751 | Nea 13 Gp, Ltd | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No | |
| 1460752 | Nea Partners 13, Limited Partnership | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-10-08 | 3,416,569 | $0.00 | 3,433,810 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-10-08 | 69,112 | $16.00 | 3,502,922 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2014-10-08 | 2,378,408 | $0.00 | 2,378,408 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2014-10-08 | 655,321 | $0.00 | 655,321 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2014-10-08 | 382,840 | $0.00 | 382,840 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- In connection with the consummation of the Issuer's initial public offering on October 8, 2014, each share of Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration. All shares of Common Stock issued upon conversion were aggregated.
- The securities are directly held by New Enterprise Associates 13, L.P. ("NEA 13") and are indirectly held by NEA Partners 13, L.P. ("NEA Partners 13"), the sole general partner of NEA 13, NEA 13 GP, LTD ("NEA 13 LTD"), the sole general partner of NEA Partners 13 and each of the individual directors of NEA 13 LTD (NEA Partners 13, NEA 13 LTD and the individual directors of NEA 13 LTD (collectively, the "Directors") together, the "Indirect Reporting Persons"). The Directors of NEA 13 LTD are M. James Barrett, Peter J. Barris, Forest Baskett, Ryan D. Drant, Patrick J. Kerins, Krishna "Kittu" Kolluri, David M. Mott, Scott D. Sandell, Ravi Viswanathan and Harry R. Weller. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 13 securities in which the Indirect Reporting Persons have no pecuniary interest.
- None.
Billionaire Hedge Funds
